Business Context and Reporting Period
This Form 8-K Current Report was filed by AGNC Investment Corp. on January 14, 2026. The filing reports a corporate governance event effective January 12, 2026, involving the expansion of the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Board Expansion: The Board of Directors increased its size from nine to ten members.
- Director Appointment: Morris A. Davis was appointed to the Board, effective January 12, 2026.
- Committee Assignment: Dr. Davis was elected to the Compensation and Corporate Governance Committee.
- Term Details: The appointment continues until the 2026 annual meeting of stockholders or until a successor is elected, qualified, or until earlier death, resignation, or removal.
Management Commentary and Background
Dr. Davis is a returning director who previously served on the Board from May 2008 to March 2025. He resigned in 2025 to serve as Chief Housing Economist at the Council of Economic Advisors to the President. His background includes:
- Paul V. Profeta Chair of Real Estate and Professor of Finance and Economics at Rutgers Business School.
- Visiting Scholar at the Federal Reserve Bank of Minneapolis and the Federal Reserve Bank of Chicago.
- Former economist at the Federal Reserve Board and James A. Graaskamp Chair at the University of Wisconsin-Madison.
- Author of research cited over 5,400 times in top academic journals.
Dr. Davis will participate in standard non-employee director compensation arrangements and will enter into a standard indemnification agreement. No family relationships or undisclosed transactions requiring Item 404(a) disclosure exist.
Investor Verification Checklist
- Verify the effective date of Dr. Davis's appointment (January 12, 2026) against the company's official board roster.
- Confirm the composition of the Compensation and Corporate Governance Committee following this appointment.
- Review the attached Form of Indemnification Agreement (Exhibit 10.1) for specific terms.
- Monitor upcoming proxy statements for the 2026 annual meeting regarding the election of directors.